GL1X · GenesisL1 explorer

Research workbench

Crystal structure of MGLUR5 in complex with mmpep at 2.2 a

Analyse Crystal structure of MGLUR5 in complex with mmpep at 2.2 a in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6FFI
Type
protein
Length
410 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Metabotropic glutamate receptor 5,ENDOLYSIN,METABOTROPIC glutamate receptor 5
EC
3.2.1.17
UniProt
P41594, P00720
Ligands
OLA, D8B
Pockets
3 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 74% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMetabotropic glutamate receptor 5,ENDOLYSIN,METABOTROPIC glutamate receptor 5 (EC 3.2.1.17)protein41074% helix, 4% strandP41594, P00720

Ligands and binding sites

  • OLA · Oleic acid · ligand · 7 copies · chains A
  • D8B · 2-[2-(3-methoxyphenyl)ethynyl]-6-methyl-pyridine · ligand · chains A
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12960.780.8955MES, D8B
24890.690.8049empty
3700.640.9125empty

Modifications

Observed in the structure: 1 disulfide, 1 modified (disulfide, alkylation).

Compared structures

  • 6FFI · Crystal Structure of mGluR5 in complex with MMPEP at 2.2 A · the same entry in another collection · chain A against A, TM-score 1.00
  • P41594 · AlphaFold monomer V2.0 prediction for metabotropic glutamate receptor 5 (P41594) · a predicted model of the same protein · chain A against A, TM-score 0.58

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.